The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11C-MET PET Study.

CONCLUSIONS: 11C-methionine PET can noninvasively evaluate the IDH1 mutation status of patients with nonenhancing supratentorial diffuse gliomas. PMID: 31889470 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31889470?dopt=Abstract

Source: Molecular Imaging - January 2, 2020 Category: Radiology Tags: Mol Imaging Source Type: research